← FDA DRUG APPROVALS

FDA ANDA · ANDA204851

METHYLTESTOSTERONE

Sponsor: IMPAX LABS INC

APPLICATION
ANDA204851
TYPE
ANDA
ORIGINAL APPROVAL
2015-09-21
LATEST ACTION
2025-07-11
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

METHYLTESTOSTERONEPrescription
METHYLTESTOSTERONE 10MG · CAPSULE · ORAL

Approval history

2025-07-11Labeling · Supplement 10 · standardAP
2016-10-25Labeling · Supplement 4 · standardAP
2015-09-21UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →